WA
GSK icon

Westfuller Advisors’s GSK GSK Stock Holding History

Westfuller Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.48K Sell
28
-13
-32% -$688 ﹤0.01% 685
2026
Q1 		$2.28K Sell
41
-18
-31% -$975 ﹤0.01% 620
2025
Q4 		$2.92K Hold
59
– – ﹤0.01% 624
2025
Q3 		$2.57K Buy
+59
New +$2.31K ﹤0.01% 615

Other funds holding GSK

JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
MHI
Miller Howard Investments Kingston, New York $3.77B AUM 23.82% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return

Westfuller Advisors's GSK Position: Q2 2026 in Review

Westfuller Advisors reduced its GSK (GSK) stake by 32% in Q2 2026, selling an estimated $688 and leaving 28 shares worth $1.48K. The position accounts for ﹤0.01% of the portfolio, ranked #685.

Westfuller Advisors first reported a position in GSK in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.92K in Q4 2025. 435 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Westfuller Advisors held 28 shares of GSK worth $1.48K as of Q2 2026.
  • Westfuller Advisors sold 13 GSK shares in Q2 2026, an estimated $688.
  • GSK made up ﹤0.01% of Westfuller Advisors's portfolio in Q2 2026, its #685 holding.
  • Westfuller Advisors first reported a position in GSK in Q3 2025 and has held it in 4 quarters since.
  • Westfuller Advisors's GSK position peaked at $2.92K in Q4 2025.
  • 435 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Westfuller Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.